Thouvenin, J.; MartÃnez Chanzá, N.; Alhalabi, O.; Lang, H.; Tannir, N.M.; Barthélémy, P.; Malouf, G.G.
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions. Cancers 2021, 13, 4341.
https://doi.org/10.3390/cancers13174341
AMA Style
Thouvenin J, MartÃnez Chanzá N, Alhalabi O, Lang H, Tannir NM, Barthélémy P, Malouf GG.
Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions. Cancers. 2021; 13(17):4341.
https://doi.org/10.3390/cancers13174341
Chicago/Turabian Style
Thouvenin, Jonathan, Nieves MartÃnez Chanzá, Omar Alhalabi, Hervé Lang, Nizar M. Tannir, Philippe Barthélémy, and Gabriel G. Malouf.
2021. "Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions" Cancers 13, no. 17: 4341.
https://doi.org/10.3390/cancers13174341
APA Style
Thouvenin, J., MartÃnez Chanzá, N., Alhalabi, O., Lang, H., Tannir, N. M., Barthélémy, P., & Malouf, G. G.
(2021). Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions. Cancers, 13(17), 4341.
https://doi.org/10.3390/cancers13174341
